Swaroopa Pulivarthi
Swaroopa Pulivarthi publishes mostly in Neurology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Multiple Myeloma Research and Treatments, Intracranial Aneurysms: Treatment and Complications and Neurofibromatosis and Schwannoma Cases.
- World rank
- #6,844,639 of 7,710,434 ranked researchers
- Rank in United States
- #1,560,958 of 1,627,098
- Works
- 16
- Citations
- 118
- Citations per work
- 7.4
What does Swaroopa Pulivarthi research?
Swaroopa Pulivarthi's work is mostly in Medicine (71%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1170.8%
- Medicine1170.8%
- Everything else529.2%
- 1Neurology39% of their works
- 2Pulmonary and Respiratory Medicine10% of their works
- 3Oncology7% of their works
- 4Pathology and Forensic Medicine5% of their works
- 5Epidemiology5% of their works
- 6Hematology5% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Intracranial Aneurysms: Treatment and Complications
- Neurofibromatosis and Schwannoma Cases
- Neuroblastoma Research and Treatments
- Vascular Malformations Diagnosis and Treatment
- Peripheral Neuropathies and Disorders
- Autoimmune Neurological Disorders and Treatments
- Cancer Treatment and Pharmacology
Which keywords describe Swaroopa Pulivarthi's research?
The keywords of their largest research topics: Genetic Mutations, Endovascular Treatment, Immunotherapy, Neurological Disorders, Prognosis, Staging System, ALK and Aneurysmal Subarachnoid Hemorrhage.
- Tumor Suppressor
- Paraneoplastic Syndromes
- Neuroblastoma
- International Myeloma Working Group
- Diagnosis Criteria
- Chemotherapy-Induced Peripheral Neuropathy
- Arteriovenous Malformations
- Aneurysmal Subarachnoid Hemorrhage
- Staging System
- Neurological Disorders
- Endovascular Treatment
- Genetic Mutations
- Immunotherapy
- Prognosis
- ALK
- Anti-NMDA Receptor Encephalitis
- Cerebral Cavernous Malformations
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Guillain-Barré Syndrome
- Intracranial Aneurysms
- Neurofibromatosis
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Genetic Mutations63 topics
- Endovascular Treatment42 topics
- Immunotherapy42 topics
- Neurological Disorders42 topics
- Prognosis42 topics
- Staging System42 topics
- ALK21 topic
- Aneurysmal Subarachnoid Hemorrhage21 topic
- Anti-NMDA Receptor Encephalitis21 topic
- Arteriovenous Malformations21 topic
- Cerebral Cavernous Malformations21 topic
- Chemotherapy-Induced Peripheral Neuropathy21 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy21 topic
- Diagnosis Criteria21 topic
- Guillain-Barré Syndrome21 topic
- International Myeloma Working Group21 topic
- Intracranial Aneurysms21 topic
- Neuroblastoma21 topic
- Neurofibromatosis21 topic
- Paraneoplastic Syndromes21 topic
- Taxanes21 topic
- Tumor Suppressor21 topic
Where does Swaroopa Pulivarthi work?
Swaroopa Pulivarthi's main affiliation in the publication record is HealthEast Care System, United States.
How many publications and citations does Swaroopa Pulivarthi have?
OpenAlex counts 16 works and 118 citations for Swaroopa Pulivarthi, an h-index of 8, ranking #6,844,639 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Swaroopa Pulivarthi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.